FDA Panel Votes Against Avastin For Breast Cancer TreatmentIn a decision that could affect millions of women, a Food and Drug Administration advisory panel found that the best-selling cancer drug in the world should not be used on breast cancer patients.

More From CBS Los Angeles

KNX 1070 Newsradio
Follow Us On Twitter

Listen Live